English 
Spanish 
TWiV 967 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 24 December 2022 pdf […]
TWiV 967 Clinical Update Read More »
February 16, 2023
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants | A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273 | The political polarization of COVID-19 treatments among physicians and laypeople in the United States | Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study | SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster | The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England
February 9, 2023
The Negative Effect of Preexisting Immunity on Influenza Vaccine |
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells |
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults | Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection | Early Treatment with Pegylated Interferon Lambda for Covid-19 | Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms |
Consistency of covid-19 trial preprints with published reports |
Peru confirms H5N1 avian flu in marine mammals | Incidence of Chronic Spontaneous Urticaria |
COVID-19 Mortality and Progress Toward Vaccinating Older Adults
Nonprofits Partner to Bring Listeners Infectious Disease Puscast
Infectious Disease Puscast is co-hosted by Dr. Griffin and Sara Winn Dong, MD, and is released bi-monthly. In each episode, the doctors discuss the newest and most relevant findings in the field of infectious diseases.
Nonprofits Partner to Bring Listeners Infectious Disease Puscast Read More »
February 2, 2023
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection | Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods | Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients | Effectiveness of Bivalent Boosters against Severe Omicron Infection |
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults | Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US |
Association of culturable-virus detection and household transmission of SARS-CoV-2 – California and Tennessee, 2020–2022 | Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients
January 24, 2023
Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19 |
Early and Increased Influenza Activity Among Children — Tennessee |
SARS-CoV-2 variant-related abnormalities detected by prenatal MRI | COVID-19 vaccines versus pediatric hospitalization |
Persistent COVID-19 Symptoms at 6 Months After Onset | Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study |
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases |
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant
January 19, 2023
Long COVID: major findings, mechanisms and recommendations | Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome | Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination | Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 | Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019
January 12, 2023
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study | Effectiveness of the Bivalent mRNA Vaccine in Preventing Severe COVID-19 Outcomes: An Observational Cohort Study | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection | Increasing Ventilation Reduces Sars-Cov-2 Airborne Transmission In Schools | Use of Carbon Dioxide Monitoring to Assess Ventilation at a National Infectious Diseases Conference
January 5, 2023
Virological characteristics of the SARS-CoV-2 XBB variant | SARS-CoV-2 infection and persistence in the human body | Long-term cardiovascular outcomes of COVID-19 | Heart-disease risk soars | Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants | Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines |
Time to negative PCR conversion among high-risk patients | The Fc-effector function of COVID-19 convalescent plasma | Infectiousness of SARS-CoV-2 breakthrough infections and reinfections
December 29, 2022
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron | Structural brain changes in post-acute COVID-19 patients | Persistent post–COVID-19 smell loss | Persistent symptoms and sequelae after SARS-CoV-2 infection | VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System | Molnupiravir plus usual care versus usual care alone as early treatment for adults | Higher dose corticosteroids in hospitalized COVID-19 patients | FDA approves Roche’s Actemra (tocilizumab) for the treatment of COVID-19 | Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine | Canine real-time detection of SARS-CoV-2 infections | Clinical Validation of a Novel T-Cell Receptor | Modelling the adjustment of COVID-19 response | Two masks can be worse than one: N95 respirator failure caused by an overlying face mask | Airflow Patterns in Double-Occupancy Patient Rooms | The epidemiology of long COVID in US adults
